{"id":"W2039457659","doi":"10.1158/1535-7163.targ-11-a221","title":"Abstract A221: A phase II study of SB939 in patients with recurrent or metastatic castration resistant prostate cancer (CRPC).","year":2011,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Internal medicine; Clinical endpoint; Oncology; Cancer; Adverse effect; Androgen deprivation therapy; Lymph node; Prostate; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001507263,0.0002621558,0.0004218085,0.000196067,0.00007241324,0.00001265024,0.0001109224,0.00004687198,0.0002256937],"category_scores_gemma":[0.000005467427,0.0001681427,0.00005367064,0.0004827848,0.00009215646,0.00008969966,0.000033846,0.0002384675,0.000001233327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003166862,"about_ca_system_score_gemma":0.0005816296,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001362027,"about_ca_topic_score_gemma":0.001978577,"domain_scores_codex":[0.9980899,0.00008112015,0.0004454519,0.0003737625,0.0006278788,0.0003818873],"domain_scores_gemma":[0.9989892,0.00001410534,0.0002073516,0.0003563194,0.0003181438,0.0001149313],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1886194,0.05796636,0.2949269,0.001366448,0.005364655,0.001651145,0.05828312,0.0001542571,0.06962842,0.0000343544,0.00006309482,0.3219419],"study_design_scores_gemma":[0.1292048,0.08129308,0.6899906,0.001730177,0.00247129,0.000005212153,0.004566714,0.0001923921,0.08847806,0.0001015884,0.001018792,0.0009473238],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994489,0.002294685,0.00001186943,0.0001214076,0.00008301422,0.00272655,0.0001133456,0.00002008185,0.000140005],"genre_scores_gemma":[0.9983226,0.0005713903,0.0002094064,0.0001052667,0.00001296809,0.0005342406,0.00004289259,0.00004986669,0.0001513855],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3950637,"threshold_uncertainty_score":0.685666,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08893729981605718,"score_gpt":0.3766998605302653,"score_spread":0.2877625607142081,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}